We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Patterson Cos. (PDCO) Down 33.5% Since Last Earnings Report: Can It Rebound?
Read MoreHide Full Article
A month has gone by since the last earnings report for Patterson Cos. (PDCO - Free Report) . Shares have lost about 33.5% in that time frame, underperforming the S&P 500.
Will the recent negative trend continue leading up to its next earnings release, or is Patterson Cos. due for a breakout? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important catalysts.
Patterson Companies Q3 Earnings Top Estimates, Up Y/Y
Patterson Companies, Inc. reported adjusted earnings per share of 47 cents in third-quarter fiscal 2020, which beat the Zacks Consensus Estimate by 27%. Moreover, the bottom line improved 23.7% from the prior-year quarter.
Net sales in the quarter were $1.46 billion, outpacing the Zacks Consensus Estimate by 2.8%. The top line also rose 4.3% year over year.
Segmental Analysis
The company currently distributes products through subsidiaries Patterson Dental and Patterson Animal Health.
Dental Segment
This segment provides a complete range of consumable dental products, equipment, software, turnkey digital solutions and value-added services to dentists, and laboratories throughout North America.
In the fiscal third quarter, dental sales improved 8.1% year over year to approximately $626.6 million.
Dental Consumable
Sales in the sub-segment totaled $300.4 million, up 1.9% year over year.
Dental Equipment & Software
Sales in the segment improved 16.2% on a year-over-year basis to $252.9 million. Other
This segment comprises technical service, parts and labor, software support services and office supplies. Sales at the segment improved 8.8% on a year-over-year basis to $73.3 million.
Animal Health Segment
This segment is a leading distributor of veterinary supplies to clinics, public and private institutions and shelters across the United States. In the fiscal third quarter, the segment sales improved 1.2% on a year-over-year basis to $817.3 million.
Corporate
Sales at the segment were $12.3 million, up 29% from $9.5 million reported in the year-ago quarter.
Gross Margin Analysis
Gross profit in the reported quarter was $311.8 million, up 4.1% year over year. As a percentage of revenues, gross margin of 21.4%, remaining flat on year-over-year basis.
Operating expenses in the reported quarter totaled $268 million, up 5.5% on a year-over-year basis.
Operating income was $43.8 million, down 3.4% from the year-ago quarter.
Fiscal 2020 Guidance Raised
For fiscal 2020, Patterson Companies now expects adjusted earnings per share in the range of $1.50 to $1.55 (up from the prior range of $1.36-$1.46). The mid-point of the guidance of $1.53 is above the Zacks Consensus Estimate of $1.42 per share.
How Have Estimates Been Moving Since Then?
In the past month, investors have witnessed a downward trend in estimates review.
VGM Scores
Currently, Patterson Cos. has a poor Growth Score of F, however its Momentum Score is doing a bit better with a D. However, the stock was allocated a grade of B on the value side, putting it in the second quintile for this investment strategy.
Overall, the stock has an aggregate VGM Score of D. If you aren't focused on one strategy, this score is the one you should be interested in.
Outlook
Estimates have been broadly trending downward for the stock, and the magnitude of these revisions indicates a downward shift. Notably, Patterson Cos. has a Zacks Rank #2 (Buy). We expect an above average return from the stock in the next few months.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Patterson Cos. (PDCO) Down 33.5% Since Last Earnings Report: Can It Rebound?
A month has gone by since the last earnings report for Patterson Cos. (PDCO - Free Report) . Shares have lost about 33.5% in that time frame, underperforming the S&P 500.
Will the recent negative trend continue leading up to its next earnings release, or is Patterson Cos. due for a breakout? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important catalysts.
Patterson Companies Q3 Earnings Top Estimates, Up Y/Y
Patterson Companies, Inc. reported adjusted earnings per share of 47 cents in third-quarter fiscal 2020, which beat the Zacks Consensus Estimate by 27%. Moreover, the bottom line improved 23.7% from the prior-year quarter.
Net sales in the quarter were $1.46 billion, outpacing the Zacks Consensus Estimate by 2.8%. The top line also rose 4.3% year over year.
Segmental Analysis
The company currently distributes products through subsidiaries Patterson Dental and Patterson Animal Health.
Dental Segment
This segment provides a complete range of consumable dental products, equipment, software, turnkey digital solutions and value-added services to dentists, and laboratories throughout North America.
In the fiscal third quarter, dental sales improved 8.1% year over year to approximately $626.6 million.
Dental Consumable
Sales in the sub-segment totaled $300.4 million, up 1.9% year over year.
Dental Equipment & Software
Sales in the segment improved 16.2% on a year-over-year basis to $252.9 million.
Other
This segment comprises technical service, parts and labor, software support services and office supplies. Sales at the segment improved 8.8% on a year-over-year basis to $73.3 million.
Animal Health Segment
This segment is a leading distributor of veterinary supplies to clinics, public and private institutions and shelters across the United States.
In the fiscal third quarter, the segment sales improved 1.2% on a year-over-year basis to $817.3 million.
Corporate
Sales at the segment were $12.3 million, up 29% from $9.5 million reported in the year-ago quarter.
Gross Margin Analysis
Gross profit in the reported quarter was $311.8 million, up 4.1% year over year. As a percentage of revenues, gross margin of 21.4%, remaining flat on year-over-year basis.
Operating expenses in the reported quarter totaled $268 million, up 5.5% on a year-over-year basis.
Operating income was $43.8 million, down 3.4% from the year-ago quarter.
Fiscal 2020 Guidance Raised
For fiscal 2020, Patterson Companies now expects adjusted earnings per share in the range of $1.50 to $1.55 (up from the prior range of $1.36-$1.46). The mid-point of the guidance of $1.53 is above the Zacks Consensus Estimate of $1.42 per share.
How Have Estimates Been Moving Since Then?
In the past month, investors have witnessed a downward trend in estimates review.
VGM Scores
Currently, Patterson Cos. has a poor Growth Score of F, however its Momentum Score is doing a bit better with a D. However, the stock was allocated a grade of B on the value side, putting it in the second quintile for this investment strategy.
Overall, the stock has an aggregate VGM Score of D. If you aren't focused on one strategy, this score is the one you should be interested in.
Outlook
Estimates have been broadly trending downward for the stock, and the magnitude of these revisions indicates a downward shift. Notably, Patterson Cos. has a Zacks Rank #2 (Buy). We expect an above average return from the stock in the next few months.